{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:21:55Z","timestamp":1767918115182,"version":"3.49.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:00:00Z","timestamp":1527120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/02935-2"],"award-info":[{"award-number":["2015\/02935-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s12020-018-1624-2","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T09:47:43Z","timestamp":1527155263000},"page":"242-249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Evaluation of melatonin and AFMK levels in women with breast cancer"],"prefix":"10.1007","volume":"62","author":[{"given":"Tialfi Bergamin","family":"de Castro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Newton Ant\u00f4nio","family":"Bordin-Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Alves","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0146-9041","authenticated-orcid":false,"given":"Debora Aparecida Pires","family":"de Campos Zuccari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,24]]},"reference":[{"key":"1624_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3322\/caac.21218","volume":"64","author":"RG Stevens","year":"2014","unstructured":"R.G. Stevens, G.C. Brainard, D.E. Blask, S.W. Lockley, M.E. Motta, Breast cancer and circadian disruption from electric lighting in the modern world. CA Cancer J. Clin. 64, 207 (2014)","journal-title":"CA Cancer J. Clin."},{"key":"1624_CR2","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1530\/ERC-15-0030","volume":"22","author":"SM Hill","year":"2015","unstructured":"S.M. Hill, V.P. Belancio, R.T. Dauchy, S. Xiang, S. Brimer, L. Mao, A. Hauch, P.W. Lundberg, W. Summers, L. Yuan, T. Frasch, D.E. Blask, Melatonin: An inhibitor of breast cancer. Endocr. Relat. Cancer 22, R183 (2015)","journal-title":"Endocr. Relat. Cancer"},{"key":"1624_CR3","first-page":"1","volume":"6412","author":"Z Xie","year":"2017","unstructured":"Z. Xie, F. Chen, W.A. Li, X. Geng, C. Li, X. Meng, Y. Feng, W. Liu, F. Yu, A review of sleep disorders and melatonin. Neurol. Res. 6412, 1 (2017)","journal-title":"Neurol. Res."},{"key":"1624_CR4","first-page":"5","volume":"44","author":"JaS Neto","year":"2008","unstructured":"Ja.S. Neto, B.F. De Castro, Melatonina, ritmos biol\u00f3gicos e sono \u2013uma revis\u00e3o da literatura. Rev. Bras. Neurol. 44, 5 (2008)","journal-title":"Rev. Bras. Neurol."},{"key":"1624_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1210\/edrv-12-2-151","volume":"12","author":"RJ Reiter","year":"1991","unstructured":"R.J. Reiter, Pineal melatonin: Cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12, 151 (1991)","journal-title":"Endocr. Rev."},{"key":"1624_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/670294","volume":"2012","author":"J Espino","year":"2012","unstructured":"J. Espino, J.A. Pariente, A.B. Rodr\u00edguez, Oxidative stress and immunosenescence: Therapeutic effects of melatonin. Oxid. Med. Cell Longev. 2012, 1 (2012)","journal-title":"Oxid. Med. Cell Longev."},{"key":"1624_CR7","first-page":"109","volume":"5","author":"V Srinivasan","year":"2011","unstructured":"V. Srinivasan, G. Maestroni, D. Cardinali, A. Esquifino, S.P. Perumal, S. Miller, Melatonin, immune function and aging. Immun. Ageing 5, 109 (2011)","journal-title":"Immun. Ageing"},{"key":"1624_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1042\/BJ20042075","volume":"388","author":"G Ferry","year":"2005","unstructured":"G. Ferry, C. Ubeaud, P.-H. Lambert, S. Bertin, F. Cog\u00e9, P. Chomarat, P. Delagrange, B. Serkiz, J.-P. Bouchet, R.J.W. Truscott, J.A. Boutin, Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan: Investigations with both indoleamine 2,3-dioxygenase and myeloperoxidase. Biochem. J. 388, 205 (2005)","journal-title":"Biochem. J."},{"key":"1624_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1124\/pr.110.002832","volume":"62","author":"ML Dubocovich","year":"2010","unstructured":"M.L. Dubocovich, P. Delagrange, D.N. Krause, D. Sugden, D.P. Cardinali, J. Olcese, Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmocological. Rev. 62, 343 (2010)","journal-title":"Pharmocological. Rev."},{"key":"1624_CR10","first-page":"411","volume":"67","author":"J Jaworek","year":"2016","unstructured":"J. Jaworek, J. Szklarczyk, J. Bonior, M. Kot, M. Goralska, P. Pierzchalski, R.J. Reiter, U. Czech, R. Tomaszewska, Melatonin metabolite, N1-acetyl-N1-formyl-5-methoxykynuramine (AFMK), attenuates acute pancreatitis in the rat: In vivo and in vitro studies. J. Physiol. Pharmacol. 67, 411 (2016)","journal-title":"J. Physiol. Pharmacol."},{"key":"1624_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/MOG.0b013e32835c9cb3","volume":"29","author":"MA Ciorba","year":"2013","unstructured":"M.A. Ciorba, Indoleamine 2,3 dioxygenase in intestinal disease. Curr. Opin. Gastroenterol. 29, 146 (2013)","journal-title":"Curr. Opin. Gastroenterol."},{"key":"1624_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1600-079X.2004.00149.x","volume":"37","author":"SO Silva","year":"2004","unstructured":"S.O. Silva, M.R. Rodrigues, S.R.Q. Carvalho, L.H. Catalani, A. Campa, V.F. Ximenes, Oxidation of melatonin and its catabolites, N1-acetyl-N 2-formyl-5-methoxykynuramine and N1-acetyl-5- methoxykynuramine, by activated leukocytes. J. Pineal Res. 37, 171 (2004)","journal-title":"J. Pineal Res."},{"key":"1624_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1590\/S0104-42302008000300022","volume":"54","author":"CC Maganhin","year":"2008","unstructured":"C.C. Maganhin, A.A.F. Carbonel, J.H. Hatty, L.F.P. Fuchs, I.S. de Oliveira-J\u00fanior, M. de, J. Sim\u00f5es, R.S. Sim\u00f5es, E.C. Baracat, J.M. Soares Jr., Efeitos da melatonina no sistema genital feminino: Breve revis\u00e3o. Rev. Assoc. Med. Bras. 54, 267 (2008)","journal-title":"Rev. Assoc. Med. Bras."},{"issue":"3","key":"1624_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/jpi.12360","volume":"61","author":"Russel J. Reiter","year":"2016","unstructured":"R.J. Reiter, J.C. Mayo, D.X. Tan, R.M. Sainz, M. Alatorre-Jimenez, and L. Qin. Melatonin as an antioxidant: Under promises but over delivers. J. Pineal Res. 253, 253\u2013278 (2016)","journal-title":"Journal of Pineal Research"},{"key":"1624_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.lfs.2017.06.013","volume":"183","author":"GB Gelaleti","year":"2017","unstructured":"G.B. Gelaleti, T.F. Borin, L.B. Maschio-Signorini, M.G. Moschetta, B.V. Jardim-Perassi, G.B. Calvinho, M.C. Facchini, A.M. Viloria-Petit, D.A.P. de Campos Zuccari, Efficacy of melatonin, IL-25 and siIL-17B in tumorigenesis-associated properties of breast cancer cell lines. Life Sci. 183, 98 (2017)","journal-title":"Life Sci."},{"key":"1624_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2174\/1871520615666150511094201","volume":"16","author":"BV Jardim-Perassi","year":"2016","unstructured":"B.V. Jardim-Perassi, M.R. Louren\u00e7o, G.M. Doho, I.H. Gr\u00edgolo, G.B. Gelaleti, L.C. Ferreira, T.F. Borin, M.G. Moschetta, D.A. Pires de Campos Zuccari, Melatonin regulates angiogenic factors under hypoxia in breast cancer cell lines. Anticancer Agents Med. Chem. 16, 347 (2016)","journal-title":"Anticancer Agents Med. Chem."},{"key":"1624_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jpi.12270","volume":"60","author":"TF Borin","year":"2016","unstructured":"T.F. Borin, A.S. Arbab, G.B. Gelaleti, L.C. Ferreira, M.G. Moschetta, B.V. Jardim-Perassi, A. Iskander, N.R.S. Varma, A. Shankar, V.B. Coimbra, V.A. Fabri, J.G. de Oliveira, D.A.P. de C. Zuccari, Melatonin decreases breast cancer metastasis by modulating rho-associated kinase protein-1 expression. J. Pineal Res. 60, 3 (2016)","journal-title":"J. Pineal Res."},{"key":"1624_CR18","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/jnci\/93.20.1563","volume":"93","author":"ES Schernhammer","year":"2001","unstructured":"E.S. Schernhammer, F. Laden, F.E. Speizer, W.C. Willett, D.J. Hunter, I. Kawachi, G.A. Colditz, Rotating night shifts and risk of breast cancer in women participating in the nurses\u2019 health study. J. Natl. Cancer Inst. 93, 1563 (2001)","journal-title":"J. Natl. Cancer Inst."},{"key":"1624_CR19","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S1470-2045(07)70373-X","volume":"8","author":"K Straif","year":"2007","unstructured":"K. Straif, R. Baan, Y. Grosse, B. Secretan, F. El Ghissassi, V. Bouvard, A. Altieri, L. Benbrahim-Tallaa, V. Cogliano; WHO International Agency For Research on Cancer Monograph Working Group, Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 8, 1065 (2007)","journal-title":"Lancet Oncol."},{"key":"1624_CR20","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1126\/science.1067262","volume":"295","author":"DM Berson","year":"2002","unstructured":"D.M. Berson, F.A. Dunn, M. Takao, Phototransduction by retinal ganglion cells that set the circadian clock. Science 295, 1070 (2002)","journal-title":"Science"},{"key":"1624_CR21","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrn1177","volume":"4","author":"MH Hastings","year":"2003","unstructured":"M.H. Hastings, A.B. Reddy, E.S. Maywood, A Clockwork web: Circadian timing in brain and periphery, in health and disease. Nat. Rev. Neurosci. 4, 649 (2003)","journal-title":"Nat. Rev. Neurosci."},{"key":"1624_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.mce.2012.01.004","volume":"351","author":"RM Slominski","year":"2012","unstructured":"R.M. Slominski, R.J. Reiter, N. Schlabritz-Loutsevitch, R.S. Ostrom, A.T. Slominski, Melatonin membrane receptors in peripheral tissues: Distribution and functions. Mol. Cell. Endocrinol. 351, 152 (2012)","journal-title":"Mol. Cell. Endocrinol."},{"key":"1624_CR23","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.4161\/cc.7.9.5886","volume":"7","author":"MP Antoch","year":"2008","unstructured":"M.P. Antoch, V.Y. Gorbacheva, O. Vykhovanets, I.A. Toshkov, R.V. Kondratov, A.A. Kondratova, C. Lee, A.Y. Nikitin, Disruption of the circadian clock due to the clock mutation has discrete effects on aging and carcinogenesis. Cell Cycle 7, 1197 (2008)","journal-title":"Cell Cycle"},{"key":"1624_CR24","doi-asserted-by":"publisher","first-page":"6828","DOI":"10.1158\/0008-5472.CAN-05-1119","volume":"65","author":"MA Gauger","year":"2005","unstructured":"M.A. Gauger, A. Sancar., Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res. 65, 6828 (2005)","journal-title":"Cancer Res."},{"key":"1624_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10549-004-6603-z","volume":"91","author":"S You","year":"2005","unstructured":"S. You, P.A. Wood, Y. Xiong, M. Kobayashi, J. Du-Quiton, W.J.M. Hrushesky, Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res. Treat. 91, 47 (2005)","journal-title":"Breast Cancer Res. Treat."},{"key":"1624_CR26","first-page":"1003","volume":"216","author":"L Tamarkin","year":"1982","unstructured":"L. Tamarkin, D. Danforth, A. Lichter, E. DeMoss, M. Cohen, B. Chabner, M. Lippman, Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast. Cancer Sci. 216, 1003 (1982)","journal-title":"Cancer Sci."},{"key":"1624_CR27","doi-asserted-by":"publisher","first-page":"6405","DOI":"10.1523\/JNEUROSCI.21-16-06405.2001","volume":"21","author":"GC Brainard","year":"2001","unstructured":"G.C. Brainard, J.P. Hanifin, J.M. Greeson, B. Byrne, G. Glickman, E. Gerner, M.D. Rollag, Action spectrum for melatonin regulation in humans: Evidence for a novel circadian photoreceptor. J. Neurosci. 21, 6405 (2001)","journal-title":"J. Neurosci."},{"issue":"Suppl 2","key":"1624_CR28","first-page":"17","volume":"23","author":"G Glickman","year":"2002","unstructured":"G. Glickman, R. Levin, G.C. Brainard, Ocular input for human melatonin regulation: Relevance to breast cancer. Neuro. Endocrinol. Lett. 23(Suppl 2), 17 (2002)","journal-title":"Neuro. Endocrinol. Lett."},{"key":"1624_CR29","first-page":"1398","volume":"77","author":"JR Gaddy","year":"1993","unstructured":"J.R. Gaddy, M.D. Rollag, G.C. Brainard, Pupil size regulation of threshold of light-induced melatonin suppression. J. Clin. Endocrinol. Metab. 77, 1398 (1993)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1624_CR30","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1152\/japplphysiol.00165.2011","volume":"110","author":"C Cajochen","year":"2011","unstructured":"C. Cajochen, S. Frey, D. Anders, J. Spati, M. Bues, A. Pross, R. Mager, A. Wirz-Justice, O. Stefani, Evening exposure to a light-emitting diodes (LED)-backlit computer screen affects circadian physiology and cognitive performance. J. Appl. Physiol. 110, 1432 (2011)","journal-title":"J. Appl. Physiol."},{"issue":"Pt 3","key":"1624_CR31","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1469-7793.2000.00695.x","volume":"526","author":"JM Zeitzer","year":"2000","unstructured":"J.M. Zeitzer, D.J. Dijk, R. Kronauer, E. Brown, C. Czeisler, Sensitivity of the human circadian pacemaker to nocturnal light: Melatonin phase resetting and suppression. J. Physiol. 526(Pt 3), 695 (2000)","journal-title":"J. Physiol."},{"key":"1624_CR32","doi-asserted-by":"publisher","first-page":"E463","DOI":"10.1210\/jc.2010-2098","volume":"96","author":"JJ Gooley","year":"2011","unstructured":"J.J. Gooley, K. Chamberlain, K.A. Smith, S.B.S. Khalsa, S.M.W. Rajaratnam, E. Van Reen, J.M. Zeitzer, C.A. Czeisler, S.W. Lockley, Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. J. Clin. Endocrinol. Metab. 96, E463 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1624_CR33","unstructured":"E. Cordina-Duverger, F. Menegaux, A. Popa, S. Rabstein, V. Harth, B. Pesch, T. Br\u00fcning, L. Fritschi, D.C. Glass, J.S. Heyworth, T.C. Erren, G. Casta\u00f1o-Vinyals, K. Papantoniou, A. Espinosa, M. Kogevinas, A. Grundy, J.J. Spinelli, K.J. Aronson, P. Gu\u00e9nel. Night shift work and breast cancer: A pooled analysis of population-based case\u2013control studies with complete work history. Eur. J. Epidemiol. 1, 1\u201311 (2018)"},{"key":"1624_CR34","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/1097-0142(19890715)64:2<426::AID-CNCR2820640215>3.0.CO;2-O","volume":"64","author":"C Bartsch","year":"1989","unstructured":"C. Bartsch, H. Bartsch, U. Fuchs, T.H. Lippert, O. Bellmann, D. Gupta, Stage\u2010dependent depression of melatonin in patients with primary breast cancer. Correlation with prolactin, thyroid stimulating hormone, and steroid receptors. Cancer 64, 426 (1989)","journal-title":"Cancer"},{"key":"1624_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10549-010-0958-0","volume":"127","author":"SM Hill","year":"2011","unstructured":"S.M. Hill, C. Cheng, L. Yuan, L. Mao, R. Jockers, B. Dauchy, T. Frasch, D.E. Blask, Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin. Breast Cancer Res. Treat. 127, 91 (2011)","journal-title":"Breast Cancer Res. Treat."},{"key":"1624_CR36","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1158\/0008-5472.CAN-13-3156","volume":"74","author":"RT Dauchy","year":"2014","unstructured":"R.T. Dauchy, S. Xiang, L. Mao, S. Brimer, M.A. Wren, L. Yuan, M. Anbalagan, A. Hauch, T. Frasch, B.G. Rowan, D.E. Blask, S.M. Hill, Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer. Cancer Res. 74, 4099 (2014)","journal-title":"Cancer Res."},{"key":"1624_CR37","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/BF01613283","volume":"117","author":"DE Blask","year":"1991","unstructured":"D.E. Blask, D.B. Pelletier, S.M. Hill, A. Lemus-Wilson, D.S. Grosso, S.T. Wilson, M.E. Wise, Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: Potential involvement of antiestrogenic mechanisms in vivo. J. Cancer Res. Clin. Oncol. 117, 526 (1991)","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"1624_CR38","first-page":"5","volume":"47","author":"P Kubatka","year":"2001","unstructured":"P. Kubatka, B. Bojkov\u00e1, K. M\u00f4cikov\u00e1-Kalick\u00e1, M. Mn\u00edchov\u00e1-Chamilov\u00e1, E. Ad\u00e1mekov\u00e1, I. Ahlers, E. Ahlersov\u00e1, M. \u010cerm\u00e1kov\u00e1, Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female sprague-dawley rats. Folia Biol. (Praha) 47, 5 (2001)","journal-title":"Folia Biol. (Praha)"},{"key":"1624_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150407","volume":"11","author":"N do","year":"2016","unstructured":"N. do, N. Gon\u00e7alves, J. Colombo, J.R. Lopes, G.B. Gelaleti, M.G. Moschetta, N.M. Sonehara, E. Hellm\u00e9n, C. de, F. Zanon, S.M. Oliani, D.A.P. de C. Zuccari, Effect of melatonin in epithelial mesenchymal transition markers and invasive properties of breast cancer stem cells of canine and human cell lines. PLoS ONE 11, e0150407 (2016)","journal-title":"PLoS ONE"},{"key":"1624_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2794","volume":"12","author":"L Mao","year":"2010","unstructured":"L. Mao, L. Yuan, L.M. Slakey, F.E. Jones, M.E. Burow, S.M. Hill, Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway. Breast Cancer Res. 12, R107 (2010)","journal-title":"Breast Cancer Res."},{"key":"1624_CR41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/iep.12094","volume":"95","author":"P Orend\u00e1\u0161","year":"2014","unstructured":"P. Orend\u00e1\u0161, P. Kubatka, B. Bojkov\u00e1, M. Kassayov\u00e1, K. Kajo, D. V\u00fdbohov\u00e1, P. Kru\u017eliak, M. P\u00e9\u010d, M. Adamkov, A. Kapinov\u00e1, K. Adamicov\u00e1, V. Sadlo\u0148ov\u00e1, M. Chmelov\u00e1, N. Stoll\u00e1rov\u00e1, Melatonin potentiates the anti-tumour effect of pravastatin in rat mammary gland carcinoma model. Int. J. Exp. Pathol. 95, 401 (2014)","journal-title":"Int. J. Exp. Pathol."},{"key":"1624_CR42","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1038\/bjc.1998.357","volume":"77","author":"KM Eck","year":"1998","unstructured":"K.M. Eck, L. Yuan, L. Duffy, P.T. Ram, S. Ayettey, I. Chen, C.S. Cohn, J.C. Reed, S.M. Hill, A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells. Br. J. Cancer 77, 2129 (1998)","journal-title":"Br. J. Cancer"},{"key":"1624_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2005.01.005","volume":"227","author":"K Melancon","year":"2005","unstructured":"K. Melancon, Q. Cheng, T.L. Kiefer, J. Dai, L. Lai, C. Dong, L. Yuan, A. Collins, A. Thiyagarajah, S. Long, S.M. Hill, Regression of NMU-induced mammary tumors with the combination of melatonin and 9-cis-retinoic acid. Cancer Lett. 227, 39 (2005)","journal-title":"Cancer Lett."},{"key":"1624_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11010-008-9890-6","volume":"319","author":"SS Moselhy","year":"2008","unstructured":"S.S. Moselhy, M.A.B. Al mslmani, Chemopreventive effect of lycopene alone or with melatonin against the genesis of oxidative stress and mammary tumors induced by 7,12 dimethyl(a)benzanthracene in sprague dawely female rats. Mol. Cell. Biochem. 319, 175 (2008)","journal-title":"Mol. Cell. Biochem."},{"key":"1624_CR45","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00381-010-1278-8","volume":"27","author":"EA Almeida De","year":"2011","unstructured":"E.A. De Almeida, P. Di Mascio, T. Harumi, D.W. Spence, A. Moscovitch, R. Hardeland, D.P. Cardinali, G.M. Brown, S.R. Pandi-Perumal, Measurement of melatonin in body fluids: Standards, protocols and procedures. Child\u2019s Nerv. Syst. 27, 879 (2011)","journal-title":"Child\u2019s Nerv. Syst."},{"key":"1624_CR46","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1007\/s00018-014-1579-2","volume":"71","author":"D Acu\u00f1a-Castroviejo","year":"2014","unstructured":"D. Acu\u00f1a-Castroviejo, G. Escames, C. Venegas, M.E. D\u00edaz-Casado, E. Lima-Cabello, L.C. L\u00f3pez, S. Rosales-Corral, D.-X. Tan, R.J. Reiter, Extrapineal melatonin: Sources, regulation, and potential functions. Cell. Mol. Life Sci. 71, 2997 (2014)","journal-title":"Cell. Mol. Life Sci."},{"key":"1624_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124384","volume":"10","author":"WH Talib","year":"2015","unstructured":"W.H. Talib, S. Saleh, Propionibacterium acnes augments antitumor, anti-angiogenesis and immunomodulatory effects of melatonin on breast cancer implanted in mice. PLoS ONE 10, e0124384 (2015)","journal-title":"PLoS ONE"},{"key":"1624_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jpi.12394","volume":"62","author":"W Ren","year":"2017","unstructured":"W. Ren, G. Liu, S. Chen, J. Yin, J. Wang, B. Tan, G. Wu, F.W. Bazer, Y. Peng, T. Li, R.J. Reiter, Y. Yin, Melatonin signaling in T Cells: functions and applications. J. Pineal Res. 62, 1 (2017)","journal-title":"J. Pineal Res."},{"key":"1624_CR49","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/molecules23020336","volume":"23","author":"A Gonz\u00e1lez-Gonz\u00e1lez","year":"2018","unstructured":"A. Gonz\u00e1lez-Gonz\u00e1lez, M.D. Mediavilla, E.J. S\u00e1nchez-Barcel\u00f3., Melatonin, A molecule for reducing breast cancer risk. Molecules 23, 336 (2018)","journal-title":"Molecules"},{"key":"1624_CR50","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/jcp.20461","volume":"206","author":"PJ Lardone","year":"2006","unstructured":"P.J. Lardone, A. Carrillo-Vico, M.C. Naranjo, B. De Felipe, A. Vallejo, M. Karasek, J.M. Guerrero, Melatonin synthesized by jurkat human leukemic T cell line is implicated in IL-2 production. J. Cell. Physiol. 206, 273 (2006)","journal-title":"J. Cell. Physiol."},{"key":"1624_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/jpi.12162","volume":"57","author":"H Zhang","year":"2014","unstructured":"H. Zhang, Y. Zhang., Melatonin: A well\u2010documented antioxidant with conditional pro\u2010oxidant actions. J. Pineal Res. 57, 131 (2014)","journal-title":"J. Pineal Res."},{"key":"1624_CR52","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/apha.12470","volume":"213","author":"Y Chen","year":"2015","unstructured":"Y. Chen, M. Leon-Ponte, S.C. Pingle, P.J. O\u2019Connell, G.P. Ahern, T lymphocytes possess the machinery for 5-HT synthesis, storage, degradation and release. Acta Physiol. (Oxf.). 213, 860 (2015)","journal-title":"Acta Physiol. (Oxf.)."},{"key":"1624_CR53","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/ni1003","volume":"4","author":"F Fallarino","year":"2003","unstructured":"F. Fallarino, U. Grohmann, K.W. Hwang, C. Orabona, C. Vacca, R. Bianchi, M.L. Belladonna, M.C. Fioretti, M.-L. Alegre, P. Puccetti, Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4, 1206 (2003)","journal-title":"Nat. Immunol."},{"key":"1624_CR54","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1084\/jem.20020052","volume":"196","author":"P Terness","year":"2002","unstructured":"P. Terness, T.M. Bauer, L. R\u00f6se, C. Dufter, A. Watzlik, H. Simon, G. Opelz, Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: Mediation of suppression by tryptophan metabolites. J. Exp. Med. 196, 447 (2002)","journal-title":"J. Exp. Med."},{"key":"1624_CR55","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00262-014-1549-4","volume":"63","author":"GC Prendergast","year":"2014","unstructured":"G.C. Prendergast, C. Smith, S. Thomas, L. Mandik-Nayak, L. Laury-Kleintop, R. Metz, A.J. Muller, Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer. Cancer Immunol. Immunother. 63, 721 (2014)","journal-title":"Cancer Immunol. Immunother."},{"key":"1624_CR56","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.18632\/oncotarget.6467","volume":"7","author":"B Heng","year":"2016","unstructured":"B. Heng, C.K. Lim, D.B. Lovejoy, A. Bessede, L. Gluch, G.J. Guillemin, Understanding the role of the kynurenine pathway in human breast cancer immunobiology. Oncotarget 7, 6506 (2016)","journal-title":"Oncotarget"},{"key":"1624_CR57","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40425-017-0285-7","volume":"5","author":"DE Carvajal-Hausdorf","year":"2017","unstructured":"D.E. Carvajal-Hausdorf, N. Mani, V. Velcheti, K.A. Schalper, D.L. Rimm, Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer. J. Immunother. Cancer 5, 81 (2017)","journal-title":"J. Immunother. Cancer"},{"key":"1624_CR58","first-page":"711","volume":"66","author":"A Leja-Szpak","year":"2015","unstructured":"A. Leja-Szpak, P. Pierzchalski, M. Goralska, K. Nawrot-Porabka, J. Bonior, P. Link-Lenczowski, M. Jastrzebska, J. Jaworek, Kynuramines induce overexpression of heat shock proteins in pancreatic cancer cells via 5-hydroxytryptamine and MT1\/MT2 receptors. J. Physiol. Pharmacol. 66, 711 (2015)","journal-title":"J. Physiol. Pharmacol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1624-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1624-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1624-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T11:00:45Z","timestamp":1604314845000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1624-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,24]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1624"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1624-2","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,24]]},"assertion":[{"value":"12 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}